Lumir Ventures

Lumir Ventures is a venture capital firm founded in 2021 and based in Melbourne, Australia. The firm focuses on collaborating with exceptional Israeli entrepreneurs to create global technology companies. It targets early and growth-stage technology ventures, primarily investing in businesses located in Israel and Australia. By leveraging its network and expertise, Lumir Ventures aims to support the development of innovative solutions and contribute to the expansion of the technology sector in these regions.

Alex Dikman

Managing Partner

Dean Kavanagh

Partner

Joshua Liberman

Founding Partner

7 past transactions

Faye

Series B in 2024
Faye is a travel insurance company that offers comprehensive coverage for travelers, including health, trip, personal belongings, and even pets. The company utilizes advanced technology to enhance the travel experience, providing consumers with real-time solutions and support through a user-friendly app. Faye's automated platform focuses on resolving flight disruptions and ensuring quick claims processing and reimbursements. With 24/7 customer service specialists, Faye aims to turn travel mishaps into manageable experiences, allowing travelers to navigate unforeseen challenges with ease. The company's innovative approach redefines traditional travel insurance by prioritizing customer-centric solutions and seamless assistance throughout the journey.

WEKA

Series E in 2024
WEKA is an AI-native data platform company that provides a cloud and hardware-agnostic software solution for performance-intensive applications. Its WEKA® Data Platform enhances scalability and performance, transforming stagnant data silos into dynamic data pipelines that optimize enterprise AI, machine learning, and GPU workloads. The platform facilitates seamless data access across on-premises, cloud, edge, and hybrid multicloud environments. Serving hundreds of leading enterprises and renowned research organizations, including numerous Fortune 50 companies, WEKA addresses complex data challenges to accelerate discoveries, insights, and outcomes. The company's software-defined storage technology is tailored for high-performance and scalable file storage, making it beneficial for various industries such as life sciences, media and entertainment, financial services, and government.

Magnus Metal

Series B in 2024
Magnus Metal Ltd. is a company based in Nes Ziona, Israel, specializing in the development and manufacturing of additive casting technology. This innovative approach combines traditional casting methods with digital processes, allowing for the high-volume production of large and complex load-bearing metal parts. Magnus Metal's services cater to various industries, including industrial tooling, powertrain and engine assemblies, chassis, and structural components for applications in robotics, heavy-duty machinery, vehicles, trucks, and trains. The company's technology enhances design flexibility and supports multi-alloy capabilities, resulting in homogeneous, predictable, and accurate products while reducing costs per part.

Assured Allies

Series B in 2023
Assured Allies is focused on addressing the financial challenges families face due to aging through its longevity assurance platform. This platform employs predictive algorithms and preventive medical interventions to create individualized aging plans that include psychosocial assessments and recommended support services. By collaborating with leaders in the long-term care industry and insurance companies, Assured Allies aims to enhance the support provided to policyholders as they navigate the complexities of aging. The company’s continuous ally support further ensures that individuals receive the necessary assistance throughout their later years.

WEKA

Series D in 2022
WEKA is an AI-native data platform company that provides a cloud and hardware-agnostic software solution for performance-intensive applications. Its WEKA® Data Platform enhances scalability and performance, transforming stagnant data silos into dynamic data pipelines that optimize enterprise AI, machine learning, and GPU workloads. The platform facilitates seamless data access across on-premises, cloud, edge, and hybrid multicloud environments. Serving hundreds of leading enterprises and renowned research organizations, including numerous Fortune 50 companies, WEKA addresses complex data challenges to accelerate discoveries, insights, and outcomes. The company's software-defined storage technology is tailored for high-performance and scalable file storage, making it beneficial for various industries such as life sciences, media and entertainment, financial services, and government.

Gloat

Series D in 2022
Gloat is an innovative Internal Talent Marketplace that helps organizations optimize their workforce by connecting employees with suitable internal career opportunities based on their skills and career aspirations. The platform leverages artificial intelligence to provide real-time, personalized career recommendations while maintaining user anonymity. This approach allows individuals to make informed, data-driven career decisions and assists managers in identifying the best candidates for various roles. Gloat is utilized by prominent companies globally, including Unilever, PepsiCo, and HSBC, and operates in over 120 countries, enhancing organizational agility and providing valuable insights into talent management.

Scopio Labs

Series C in 2022
Scopio Labs Ltd., founded in 2015 and based in Tel Aviv, Israel, specializes in the development of advanced digital microscopes that utilize computational imaging technology. The company focuses on enhancing hematology diagnostics by providing tools that allow for high-resolution imaging of blood samples and bone marrow aspirates. Scopio Labs' solutions aim to improve the efficiency and accuracy of diagnosing blood-related diseases by enabling laboratories to analyze cell morphology at scale. Their offerings cater to various applications, including cancer screening, cytology, academic research, and drug discovery, thus unlocking actionable insights from complex datasets in clinical settings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.